{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:52:33Z","timestamp":1782179553775,"version":"3.54.5"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10787-025-01853-4","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T13:09:30Z","timestamp":1755004170000},"page":"4237-4274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A systematic review of the role of interleukin inhibitors in lichen planus: therapeutic and paradoxical effects"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4327-8814","authenticated-orcid":false,"given":"Amirhossein","family":"Heidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9043-2228","authenticated-orcid":false,"given":"Fatemeh","family":"Fathabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6272-7894","authenticated-orcid":false,"given":"Kimia","family":"Ghanavati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3627-9897","authenticated-orcid":false,"given":"Asma","family":"Rasouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1393-1432","authenticated-orcid":false,"given":"Sanaz","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-4926","authenticated-orcid":false,"given":"Nazila","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"1","key":"1853_CR1","doi-asserted-by":"publisher","first-page":"2201364","DOI":"10.1080\/09546634.2023.2201364","volume":"34","author":"H Ahmed","year":"2023","unstructured":"Ahmed H, Petkar M, Steinhoff M (2023) Successful treatment of rare linear lichen planopilaris with Ixekizumab. J Dermatolog Treat 34(1):2201364","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"1853_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/adj.12382","volume":"61","author":"NA Alaizari","year":"2016","unstructured":"Alaizari NA, Al-Maweri SA, Al-Shamiri HM, Tarakji B, Shugaa-Addin B (2016) Hepatitis C virus infections in oral lichen planus: a systematic review and meta-analysis. Aust Dent J 61(3):282\u2013287","journal-title":"Aust Dent J"},{"issue":"1","key":"1853_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaad.2008.09.032","volume":"61","author":"A Asarch","year":"2009","unstructured":"Asarch A, Gottlieb AB, Lee J, Masterpol KS, Scheinman PL, Stadecker MJ, Massarotti EM, Bush ML (2009) Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol 61(1):104\u2013111","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1853_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/jvc2.332","volume":"3","author":"J Belcadi","year":"2024","unstructured":"Belcadi J, Ali SO, El Ouartih I, Znati K, Senouci K, Meziane M (2024) Secukinumab-induced lichen planus. Jeadv Clinical Practice 3(2):729\u2013730","journal-title":"Jeadv Clinical Practice"},{"issue":"1","key":"1853_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/all.13954","volume":"75","author":"T Bieber","year":"2020","unstructured":"Bieber T (2020) Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis. Allergy 75(1):54\u201362","journal-title":"Allergy"},{"key":"1853_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/1744666X.2019.1559730","volume":"15","author":"C Blegvad","year":"2019","unstructured":"Blegvad C, Skov L, Zachariae C (2019) Ixekizumab for the treatment of psoriasis: an update on new data since first approval. Expert Rev Clin Immunol 15:111\u2013121","journal-title":"Expert Rev Clin Immunol"},{"key":"1853_CR7","doi-asserted-by":"publisher","first-page":"737813","DOI":"10.3389\/fmed.2021.737813","volume":"8","author":"K Boch","year":"2021","unstructured":"Boch K, Langan EA, Kridin K, Zillikens D, Ludwig RJ, Bieber K (2021) Lichen Planus. Front Med (Lausanne) 8:737813","journal-title":"Front Med (Lausanne)"},{"key":"1853_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0190-9622(91)70241-S","volume":"25","author":"AS Boyd","year":"1991","unstructured":"Boyd AS, Neldner KH (1991) Lichen planus. J Am Acad Dermatol 25:593\u2013619","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1853_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jdcr.2018.04.015","volume":"4","author":"TM Capusan","year":"2018","unstructured":"Capusan TM, Herrero-Moyano M, Martinez-Mera CR, Freih-Fraih AW, Dauden E (2018) Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event? JAAD Case Rep 4(6):521\u2013523","journal-title":"JAAD Case Rep"},{"issue":"9","key":"1853_CR10","first-page":"e938","volume":"10","author":"J Cassol-Spanemberg","year":"2018","unstructured":"Cassol-Spanemberg J, Rodriguez-de Rivera-Campillo ME, Otero-Rey EM, Estrugo-Devesa A, Jane-Salas E, Lopez-Lopez J (2018) Oral lichen planus and its relationship with systemic diseases. A review of evidence. J Clin Exp Dent 10(9):e938\u2013e944","journal-title":"J Clin Exp Dent"},{"issue":"1","key":"1853_CR11","first-page":"65","volume":"84","author":"S Chemli","year":"2006","unstructured":"Chemli S, Rym D, Jebali A, Hammami W (2006) Association lichen planus and ulcerative colitis. A case report. Tunis Med 84(1):65\u201367","journal-title":"Tunis Med"},{"key":"1853_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jdcr.2022.11.011","volume":"31","author":"PY Ch'en","year":"2023","unstructured":"Ch\u2019en PY, Song EJ (2023) Lichen planus pemphigoides successfully treated with dupilumab. JAAD Case Rep 31:56\u201358","journal-title":"JAAD Case Rep"},{"issue":"3","key":"1853_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00784-014-1288-0","volume":"19","author":"L Cigic","year":"2015","unstructured":"Cigic L, Gavic L, Simunic M, Ardalic Z, Biocina-Lukenda D (2015) Increased prevalence of celiac disease in patients with oral lichen planus. Clin Oral Investig 19(3):627\u2013635","journal-title":"Clin Oral Investig"},{"issue":"1","key":"1853_CR14","doi-asserted-by":"publisher","first-page":"21241","DOI":"10.5070\/D3201021241","volume":"20","author":"PR Cohen","year":"2014","unstructured":"Cohen PR, Kurzrock R (2014) Anakinra-responsive lichen planus in a woman with Erdheim-Chester disease: a therapeutic enigma. Dermatol Online J 20(1):21241","journal-title":"Dermatol Online J"},{"issue":"13","key":"1853_CR15","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2165\/11207530-000000000-00000","volume":"71","author":"JD Croxtall","year":"2011","unstructured":"Croxtall JD (2011) Ustekinumab: a review of its use in the management of moderate to severe plaque psoriasis. Drugs 71(13):1733\u20131753","journal-title":"Drugs"},{"issue":"3","key":"1853_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4274\/imj.galenos.2021.95815","volume":"22","author":"M Daye","year":"2021","unstructured":"Daye M, Temiz SA, G\u00fcm\u00fc\u015f S, K\u0131l\u0131n\u00e7 F (2021) Secukinumab-induced oral lichen planus: a report of case and review of literature. Istanbul Med J 22(3):235\u2013237","journal-title":"Istanbul Med J"},{"issue":"17","key":"1853_CR17","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s40265-019-01221-x","volume":"79","author":"ED Deeks","year":"2019","unstructured":"Deeks ED (2019) Dupilumab: A review in moderate to severe asthma. Drugs 79(17):1885\u20131895","journal-title":"Drugs"},{"issue":"3","key":"1853_CR18","doi-asserted-by":"publisher","first-page":"AB39","DOI":"10.1016\/j.jaad.2023.07.159","volume":"89","author":"S Desai","year":"2023","unstructured":"Desai S, Nussbaum D, Friedman A (2023) 44511 Double trouble: graham-little-piccardi-lasseur syndrome and hidradenitis suppurativa, is there a link? J Am Acad of Dermatol 89(3):AB39","journal-title":"J Am Acad of Dermatol"},{"key":"1853_CR19","doi-asserted-by":"publisher","first-page":"997190","DOI":"10.3389\/fmed.2022.997190","volume":"9","author":"D Didona","year":"2022","unstructured":"Didona D, Caposiena Caro RD, Sequeira Santos AM, Solimani F, Hertl M (2022) Therapeutic strategies for oral lichen planus: State of the art and new insights. Front Med (Lausanne) 9:997190","journal-title":"Front Med (Lausanne)"},{"key":"1853_CR20","doi-asserted-by":"crossref","unstructured":"Didona D, Pollmann R, Solimani F, Eming R, Hertl M (2021) 47th annual meeting of the arbeitsgemeinschaft dermatologische forschung (ADF): virtual, March 04-06, 2021. Exp Dermatol 30(3): e1\u2013e135","DOI":"10.1111\/exd.14263"},{"issue":"1","key":"1853_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello CA (2018) Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev 281(1):8\u201327","journal-title":"Immunol Rev"},{"key":"1853_CR22","first-page":"60","volume":"59","author":"B Doolan","year":"2018","unstructured":"Doolan B, Anderton H, Christie M, Dolianitis C (2018) Cutaneous lichen planus induced by secukinumab. Australas J Dermatol 59:60\u201361","journal-title":"Australas J Dermatol"},{"key":"1853_CR23","doi-asserted-by":"publisher","first-page":"AB70","DOI":"10.1016\/j.jaad.2024.07.286","volume":"91","author":"J Eakes","year":"2024","unstructured":"Eakes J, Hatch L, Hennessy K, Ravichandran S, Ayoubi N, Fourzali K, Yi J, Krenitsky A, Kucharik A, Correa L (2024) 50699 Pembrolizumab-Induced lichenoid drug eruption successfully treated with dupilumab \u2013 a case report. J Am Acad Dermatol 91:AB70","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1853_CR24","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/odi.14142","volume":"29","author":"A El-Howati","year":"2023","unstructured":"El-Howati A, Thornhill MH, Colley HE, Murdoch C (2023) Immune mechanisms in oral lichen planus. Oral Dis 29(4):1400\u20131415","journal-title":"Oral Dis"},{"issue":"3","key":"1853_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0738-081X(98)00004-2","volume":"16","author":"P Ellgehausen","year":"1998","unstructured":"Ellgehausen P, Elsner P, Burg G (1998) Drug-induced lichen planus. Clin Dermatol 16(3):325\u2013332","journal-title":"Clin Dermatol"},{"key":"1853_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103545","author":"MA-O Fargnoli","year":"2023","unstructured":"Fargnoli MA-O, Bardazzi F, Bianchi L, Dapavo P, Fabbrocini G, Gisondi PA-O, Micali G, Offidani AM, Pellacani G, Skroza NA-O, Angileri RG, Burlando MA-O, Campanati AA-O, Carrera CG, Chiricozzi AA-O, Conti A, Simone CA-O, Di Lernia V, Errichetti E, Galluzzo MA-O, Guarneri CA-O, Lasagni C, Lembo S, Loconsole F, Megna MA-O, Musumeci ML, Prignano FA-O, Richetta AG, Trovato EA-O, Venturini M, Peris K, Pinton PC (2023) Brodalumab for the treatment of moderate-to-severe psoriasis: an expert delphi consensus statement. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12103545","journal-title":"J Clin Med"},{"key":"1853_CR27","doi-asserted-by":"crossref","unstructured":"Lowe NJ, Cudworth AG, Clough SA, Bullen MF (1976) Carbohydrate metabolism in lichen planus. Br J Dermatol 95(1):9-12","DOI":"10.1111\/j.1365-2133.1976.tb15530.x"},{"issue":"12","key":"1853_CR28","doi-asserted-by":"publisher","first-page":"adv00619","DOI":"10.2340\/actadv.v101.442","volume":"101","author":"Z Fiocco","year":"2021","unstructured":"Fiocco Z, Kupf S, Patzak L, Kammerer T, Pumnea T, French LE, Reinholz M (2021) Quality of life and psychopathology in lichen planus: a neglected disease burden. Acta Derm Venereol 101(12):adv00619","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"1853_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cei.13449","volume":"201","author":"JM Fletcher","year":"2020","unstructured":"Fletcher JM, Moran B, Petrasca A, Smith CM (2020) IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa. Clin Exp Immunol 201(2):121\u2013134","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"1853_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s40257-018-0370-9","volume":"19","author":"JE Frampton","year":"2018","unstructured":"Frampton JE, Blair HA (2018) Dupilumab: a review in moderate-to-severe atopic dermatitis. Am J Clin Dermatol 19(4):617\u2013624","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"1853_CR31","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/1346-8138.16719","volume":"50","author":"Y Fujita","year":"2023","unstructured":"Fujita Y, Sugai T, Maya Y, Inamura E, Hirano Y, Shimizu S (2023) Secukinumab-induced oral lichen planus in a psoriatic arthritis patient ameliorated after a switch to risankizumab. J Dermatol 50(6):824\u2013827","journal-title":"J Dermatol"},{"issue":"7","key":"1853_CR32","first-page":"e41274","volume":"15","author":"FA Gajraj","year":"2023","unstructured":"Gajraj FA, Zahir J, Adereti C, Gajraj MH (2023) A case report and literature review of the role of dupilumab in the management of lichen planus: cause or treatment? Cureus 15(7):e41274","journal-title":"Cureus"},{"issue":"10","key":"1853_CR33","first-page":"e46833","volume":"15","author":"SK Gara","year":"2023","unstructured":"Gara SK, Guntipalli P, Marzban S, Taqi M, Aryal V, Khan QUA, Shah SA, Akbariromani H, Salinger D, Diaz-Miret M (2023) Clinical outcomes of ustekinumab in inflammatory bowel disease. Cureus 15(10):e46833","journal-title":"Cureus"},{"issue":"12","key":"1853_CR34","doi-asserted-by":"publisher","first-page":"13030","DOI":"10.5070\/D32612051366","volume":"26","author":"N Ghiam","year":"2020","unstructured":"Ghiam N, Ojong O, Vasile G, Romanelli P, Kerdel F (2020) Lichenoid drug eruption after treatment with ixekizumab for plaque psoriasis. Dermatol Online J 26(12):13030","journal-title":"Dermatol Online J"},{"issue":"10275","key":"1853_CR35","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerback C, Sabat R (2021) Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 397(10275):754\u2013766","journal-title":"Lancet"},{"key":"1853_CR36","doi-asserted-by":"publisher","first-page":"742826","DOI":"10.1155\/2014\/742826","volume":"2014","author":"F Gorouhi","year":"2014","unstructured":"Gorouhi F, Davari P, Fazel N (2014) Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. Sci World J 2014:742826","journal-title":"Sci World J"},{"key":"1853_CR37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.7150\/jca.17144","volume":"8","author":"L Guo","year":"2017","unstructured":"Guo L, Zhang H, Chen B (2017) Nivolumab as programmed death-1 (PD-1) inhibitor for targeted immunotherapy in tumor. J Cancer 8:410","journal-title":"J Cancer"},{"issue":"2 Pt 1","key":"1853_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0190-9622(93)70176-T","volume":"29","author":"S Halevy","year":"1993","unstructured":"Halevy S, Shai A (1993) Lichenoid drug eruptions. J Am Acad Dermatol 29(2 Pt 1):249\u2013255","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1853_CR39","doi-asserted-by":"publisher","first-page":"103818","DOI":"10.1016\/j.autrev.2025.103818","volume":"24","author":"N Heidari","year":"2025","unstructured":"Heidari N, Heidari A, Eghbali S, Pishraft-sabet H, Hajikarim-Hamedani A, Ghane Y, Lotfi Z, Goodarzi A (2025) The role of interleukin inhibitors in the treatment of hidradenitis suppurativa; a systematic review of clinical trials. Autoimmun Rev 24(7):103818","journal-title":"Autoimmun Rev"},{"issue":"10","key":"1853_CR40","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/jdv.18219","volume":"36","author":"H Husein-ElAhmed","year":"2022","unstructured":"Husein-ElAhmed H, Steinhoff M (2022) Potential role of INTERLEUKIN-17 in the pathogenesis of oral lichen planus: a systematic review with META-analysis. J Eur Acad Dermatol Venereol 36(10):1735\u20131744","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"1853_CR41","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/jdv.16464","volume":"34","author":"D Ioannides","year":"2020","unstructured":"Ioannides D, Vakirlis E, Kemeny L, Marinovic B, Massone C, Murphy R, Nast A, Ronnevig J, Ruzicka T, Cooper SM, Trueb RM, Pujol Vallverdu RM, Wolf R, Neumann M (2020) European S1 guidelines on the management of lichen planus: a cooperation of the European dermatology forum with the european academy of dermatology and venereology. J Eur Acad Dermatol Venereol 34(7):1403\u20131414","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1853_CR42","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1111\/ajd.13183","volume":"61","author":"FF Ismail","year":"2020","unstructured":"Ismail FF, Sinclair R (2020) Clinical healing of erosive oral lichen planus with tildrakizumab implicates the interleukin-23\/interleukin-17 pathway in the pathogenesis of lichen planus. Australas J Dermatol 61(2):e244\u2013e245","journal-title":"Australas J Dermatol"},{"issue":"3","key":"1853_CR43","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaad.2023.11.016","volume":"90","author":"A Kassels","year":"2024","unstructured":"Kassels A, Elsensohn AN, Kraus CN (2024) Lichen planus is associated with other autoimmune conditions: A retrospective population-level study. J Am Acad Dermatol 90(3):650\u2013652","journal-title":"J Am Acad Dermatol"},{"key":"1853_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jdcr.2022.10.019","volume":"30","author":"S Kazemi","year":"2022","unstructured":"Kazemi S, Murphrey M, Hawkes JE (2022) Rapid resolution of widespread cutaneous lichen planus and generalized pruritus in an elderly patient following treatment with dupilumab. JAAD Case Rep 30:108\u2013110","journal-title":"JAAD Case Rep"},{"issue":"3","key":"1853_CR45","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1111\/ajd.13263","volume":"61","author":"KL Kerkemeyer","year":"2020","unstructured":"Kerkemeyer KL, Pinczewski J, Sinclair R (2020) Successful treatment of recalcitrant lichen planus pemphigoides with tildrakizumab. Australas J Dermatol 61(3):e366\u2013e368","journal-title":"Australas J Dermatol"},{"issue":"3","key":"1853_CR46","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000527918","volume":"14","author":"L Kern","year":"2022","unstructured":"Kern L, Kleinheinrich L, Feldmann R, Sator P, Stella A, Breier F (2022) Dupilumab-induced lichen planus: a case with oral and cutaneous eruptions. Case Rep Dermatol 14(3):356\u2013361","journal-title":"Case Rep Dermatol"},{"key":"1853_CR47","first-page":"2168","volume":"12","author":"S Khan","year":"2020","unstructured":"Khan S, Patel S, Saipavankumar M, Hamid P (2020) Another chicken and egg story: systematic review on lichen planus as a precursor for celiac disease in adult population. Cureus 12:2168\u20138184","journal-title":"Cureus"},{"issue":"2","key":"1853_CR48","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/ajd.13553","volume":"62","author":"A Kherlopian","year":"2021","unstructured":"Kherlopian A, Fischer G (2021) Disease remission of refractory vulvovaginal and gingival lichen planus with tildrakizumab. Australas J Dermatol 62(2):246\u2013247","journal-title":"Australas J Dermatol"},{"issue":"2","key":"1853_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/ajd.13793","volume":"63","author":"A Kherlopian","year":"2022","unstructured":"Kherlopian A, Fischer G (2022) Successful treatment of vulvovaginal lichen planus with tildrakizumab: A case series of 24 patients. Australas J Dermatol 63(2):251\u2013255","journal-title":"Australas J Dermatol"},{"issue":"2","key":"1853_CR50","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1111\/ajd.14032","volume":"64","author":"A Kherlopian","year":"2023","unstructured":"Kherlopian A, Fischer G (2023) Comparing quality of life in women with vulvovaginal lichen planus treated with topical and systemic treatments using the vulvar quality of life index. Australas J Dermatol 64(2):e125\u2013e134","journal-title":"Australas J Dermatol"},{"key":"1853_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jdcr.2021.04.035","volume":"13","author":"TE Kim","year":"2021","unstructured":"Kim TE, Shin MK (2021) De novo case of lichenoid eruption following dupilumab treatment. JAAD Case Rep 13:71\u201372","journal-title":"JAAD Case Rep"},{"issue":"10378","key":"1853_CR52","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","volume":"401","author":"AB Kimball","year":"2023","unstructured":"Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG, Paul C, Giamarellos Bourboulis EJ, Villani AP, Schwinn A, Rueff F, Pillay Ramaya L, Reich A, Lobo I, Sinclair R, Passeron T, Martorell A, Mendes-Bastos P, Kokolakis G, Becherel PA, Wozniak MB, Martinez AL, Wei X, Uhlmann L, Passera A, Keefe D, Martin R, Field C, Chen L, Vandemeulebroecke M, Ravichandran S, Muscianisi E (2023) Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials. Lancet 401(10378):747\u2013761","journal-title":"Lancet"},{"issue":"7","key":"1853_CR53","doi-asserted-by":"publisher","first-page":"13030","DOI":"10.5070\/D3257044808","volume":"25","author":"AD King","year":"2019","unstructured":"King AD, Lam L, Goh C (2019) Onset of frontal fibrosing alopecia during inhibition of Th1\/17 Pathways with ustekinumab. Dermatol Online J 25(7):13030","journal-title":"Dermatol Online J"},{"issue":"6","key":"1853_CR54","first-page":"415","volume":"100","author":"RR Knisley","year":"2017","unstructured":"Knisley RR, Petropolis AA, Mackey VT (2017) Lichen planus pemphigoides treated with ustekinumab. Cutis 100(6):415\u2013418","journal-title":"Cutis"},{"key":"1853_CR55","doi-asserted-by":"publisher","first-page":"107925","DOI":"10.1016\/j.pharmthera.2021.107925","volume":"229","author":"F Kolbinger","year":"2022","unstructured":"Kolbinger F, Di Padova F, Deodhar A, Hawkes JE, Huppertz C, Kuiper T, McInnes IB, Ritchlin CT, Rosmarin D, Schett G, Carballido JM, Hausermann P, Calonder C, Vogel B, Rondeau JM, Bruin G (2022) Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety. Pharmacol Ther 229:107925","journal-title":"Pharmacol Ther"},{"issue":"4","key":"1853_CR56","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1111\/1346-8138.13637","volume":"44","author":"T Komori","year":"2017","unstructured":"Komori T, Honda T, Endo Y, Kaku Y, Otsuka A, Kabashima K (2017) Oral lichen planus associated with candidiasis during secukinumab treatment. J Dermatol 44(4):e60\u2013e61","journal-title":"J Dermatol"},{"key":"1853_CR57","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fendo.2017.00310","volume":"8","author":"D Li","year":"2017","unstructured":"Li D, Li J, Li C, Chen Q, Hua H (2017) The association of thyroid disease and oral lichen planus: a literature review and meta-analysis. Front Endocrinol (Lausanne) 8:310","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1853_CR58","doi-asserted-by":"publisher","first-page":"1023458","DOI":"10.3389\/fmed.2022.1023458","volume":"9","author":"SZ Li","year":"2022","unstructured":"Li SZ, Xie YH, Wang SH, Fang RY, Jin HZ, Zuo YG (2022) Case report: successful treatment of non-bullous lichen planus pemphigoides with dupilumab. Front Med (Lausanne) 9:1023458","journal-title":"Front Med (Lausanne)"},{"key":"1853_CR59","doi-asserted-by":"crossref","unstructured":"Liu V, Moiin A, Diaz C (2023) Lichen planus associated with secukinumab treatment for plaque psoriasis. Dermatol Online J 29(2)","DOI":"10.5070\/D329260779"},{"issue":"1","key":"1853_CR60","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bjd.16003","volume":"178","author":"R Maglie","year":"2018","unstructured":"Maglie R, Di Cesare A, Lazzeri L, Pescitelli L, Ricceri F, Vannucchi M, Massi D, Prignano F (2018) Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment. Br J Dermatol 178(1):303\u2013304","journal-title":"Br J Dermatol"},{"issue":"6","key":"1853_CR61","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1159\/000510539","volume":"237","author":"SB Mahmoud","year":"2021","unstructured":"Mahmoud SB, Anwar MK, Shaker OG, El Sharkawy DA (2021) Possible relation between vitamin D and interleukin-17 in the pathogenesis of lichen planus. Dermatology 237(6):896\u2013901","journal-title":"Dermatology"},{"key":"1853_CR62","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.2147\/CCID.S418748","volume":"16","author":"F Martora","year":"2023","unstructured":"Martora F, Scalvenzi M, Battista T, Fornaro L, Potestio L, Ruggiero A, Megna M (2023) Guselkumab, risankizumab, and tildrakizumab in the management of hidradenitis suppurativa: a review of existing trials and real-life data. Clin Cosmet Investig Dermatol 16:2525\u20132536","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"1853_CR63","first-page":"449","volume":"157","author":"L Mastorino","year":"2022","unstructured":"Mastorino L, Ortoncelli M, Giura MT, Avallone G, Viola R, Quaglino P, Ribero S (2022) Lichen ruber planus arising during dupilumab treatment for atopic dermatitis. Ital J Dermatol Venerol 157(5):449\u2013450","journal-title":"Ital J Dermatol Venerol"},{"issue":"5","key":"1853_CR64","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/jdv.18879","volume":"37","author":"JT Maul","year":"2023","unstructured":"Maul JT, Guillet C, Oschmann A, Maul LV, Meier-Schiesser B, Stadler PC, French LE, Kerl K (2023) Cutaneous lichenoid drug eruptions: A narrative review evaluating demographics, clinical features and culprit medications. J Eur Acad Dermatol Venereol 37(5):965\u2013975","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1853_CR65","doi-asserted-by":"publisher","first-page":"e13967","DOI":"10.1111\/dth.13967","volume":"33","author":"M Maurelli","year":"2020","unstructured":"Maurelli M, Colato C, Tessari G, Girolomoni G (2020) Lichen planopilaris coexisting with plaque psoriasis effectively treated with brodalumab. Dermatol Ther 33(6):e13967","journal-title":"Dermatol Ther"},{"issue":"8","key":"1853_CR66","doi-asserted-by":"publisher","first-page":"e13899","DOI":"10.1111\/cts.13899","volume":"17","author":"MR McCann","year":"2024","unstructured":"McCann MR, Kosloski MP, Xu C, Davis JD, Kamal MA (2024) Dupilumab: Mechanism of action, clinical, and translational science. Clin Transl Sci 17(8):e13899","journal-title":"Clin Transl Sci"},{"issue":"6","key":"1853_CR67","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.090074","volume":"36","author":"M Mertens","year":"2009","unstructured":"Mertens M, Singh JA (2009) Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol 36(6):1118\u20131125","journal-title":"J Rheumatol"},{"issue":"2","key":"1853_CR68","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 23(2):60\u201363","journal-title":"BMJ Evid Based Med"},{"key":"1853_CR69","unstructured":"National Heart L, aBI (2014) Quality assessment tool for observational cohort and cross-sectional studies. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"1853_CR70","unstructured":"National Heart  L, Blood Institute (2014) Quality assessment of clinical trials. https:\/\/www.nhlbi.nih.gov\/health-topics\/studyquality-assessment-tools"},{"key":"1853_CR71","unstructured":"National Heart L, Blood Institute (2014) Quality Assessment tool for before-after (Pre-Post) Studies with no control group. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"1853_CR72","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0041-1735765","volume":"10","author":"T Nosratzehi","year":"2021","unstructured":"Nosratzehi T, Alijani E, Hassanpoor N (2021) Evaluation of Salivary Interleukin-12, Interleukin-23 Levels in Patients with Oral Lichen Planus and Squamous Cell Carcinoma. Euro J Gen Dent 10:91\u201395","journal-title":"Euro J Gen Dent"},{"key":"1853_CR73","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"5","key":"1853_CR74","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/bjd\/ljae181","volume":"191","author":"T Passeron","year":"2024","unstructured":"Passeron T, Reinhardt M, Ehst B, Weiss J, Sluzevich J, Sticherling M, Reygagne P, Wohlrab J, Hertl M, Fazel N, Muscianisi E, Fan H, Hampele I, Compagno N (2024) Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study. Br J Dermatol 191(5):680\u2013690","journal-title":"Br J Dermatol"},{"key":"1853_CR75","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaad.2024.07.976","volume":"91","author":"G Peters","year":"2024","unstructured":"Peters G, Pina K, Posligua A, Durkin J (2024) 53358 Ixekizumab in patients with lichen planopilaris \u2013 an open-label study. J Am Acad Dermatol 91:246","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1853_CR76","first-page":"E8","volume":"107","author":"BT Pousti","year":"2021","unstructured":"Pousti BT, Jin A, Sklovar L, Savage KT, Zhai LL, Mollanazar NK, Heath CR (2021) Dupilumab for the treatment of lichen planus. Cutis 107(4):E8\u2013E10","journal-title":"Cutis"},{"key":"1853_CR77","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/ced\/llae425","volume":"50","author":"MH Read","year":"2024","unstructured":"Read MH, Swain E, Lovell KK, Feldman S (2024) Refractory lichen planus: success with dupilumab. Clin Exp Dermatol 50:1204\u20131205","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"1853_CR78","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1111\/jdv.17068","volume":"35","author":"C Rezzag-Mahcene","year":"2021","unstructured":"Rezzag-Mahcene C, Cardot-Leccia N, Lacour JP, Montaudi\u00e9 H, Passeron T (2021) Successful treatment of recalcitrant genital lichen planus with secukinumab. J Eur Acad Dermatol Venereol 35(5):e321\u2013e323","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1853_CR79","doi-asserted-by":"crossref","unstructured":"Romero-Jimenez B, Gruber-Velasco F, Axpe-Gil C, Barros-Eyzaguirre MJ., Roman-Sainz J, Imbernon-Moya A (2024) Successful treatment of psoriasis and lichen planus with tildrakizumab. Dermatol Online J 30(4)","DOI":"10.5070\/D330464120"},{"issue":"13","key":"1853_CR80","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","volume":"381","author":"BE Sands","year":"2019","unstructured":"Sands BE, Sandborn WJ, Panaccione R, O\u2019Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C (2019) Ustekinumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 381(13):1201\u20131214","journal-title":"N Engl J Med"},{"issue":"8","key":"1853_CR81","first-page":"1101","volume":"20","author":"E Schruf","year":"2022","unstructured":"Schruf E, Biermann MH, Jacob J, Hackl D, Reinhardt M, Hertl M, Wohlrab J (2022) Lichen planus in Germany - epidemiology, treatment, and comorbidity. A retrospective claims data analysis. J Dtsch Dermatol Ges 20(8):1101\u20131110","journal-title":"J Dtsch Dermatol Ges"},{"key":"1853_CR82","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3389\/fimmu.2019.01808","volume":"10","author":"F Solimani","year":"2019","unstructured":"Solimani F, Pollmann R, Schmidt T, Schmidt A, Zheng X, Savai R, M\u00fchlenbein S, Pickert J, Eubel V, M\u00f6bs C, Eming R, Hertl M (2019) Therapeutic targeting of Th17\/Tc17 cells leads to clinical improvement of lichen planus. Front Immunol 10:1808","journal-title":"Front Immunol"},{"key":"1853_CR83","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jdcr.2021.03.037","volume":"11","author":"EJ Song","year":"2021","unstructured":"Song EJ, Shin Wong AJ, Zhang J (2021) Psoriasiform lichen planopilaris: Unusual variant or coincidence. JAAD Case Rep 11:124\u2013126","journal-title":"JAAD Case Rep"},{"key":"1853_CR84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jdcr.2023.02.020","volume":"35","author":"J Sparks","year":"2023","unstructured":"Sparks J, Sheriff S, Burruss J (2023) Risankizumab-associated lichen planus pemphigoides. JAAD Case Rep 35:63\u201367","journal-title":"JAAD Case Rep"},{"issue":"4","key":"1853_CR85","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/154411130201300405","volume":"13","author":"PB Sugerman","year":"2002","unstructured":"Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13(4):350\u2013365","journal-title":"Crit Rev Oral Biol Med"},{"key":"1853_CR86","doi-asserted-by":"crossref","unstructured":"Tameez Ud Din A, Malik I, Arshad D, Tameez Ud Din A (2020) Dupilumab for atopic dermatitis: the silver bullet we have been searching for? Cureus 12(4):e7565","DOI":"10.7759\/cureus.7565"},{"issue":"5","key":"1853_CR87","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jdcr.2016.07.009","volume":"2","author":"JM Thompson","year":"2016","unstructured":"Thompson JM, Cohen LM, Yang CS, Kroumpouzos G (2016) Severe, ulcerative, lichenoid mucositis associated with secukinumab. JAAD Case Rep 2(5):384\u2013386","journal-title":"JAAD Case Rep"},{"issue":"4","key":"1853_CR88","doi-asserted-by":"publisher","first-page":"e13694","DOI":"10.1111\/dth.13694","volume":"33","author":"L Trindade de Carvalho","year":"2020","unstructured":"Trindade de Carvalho L, Meah N, Wall D, Sinclair R (2020) Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab. Dermatol Ther 33(4):e13694","journal-title":"Dermatol Ther"},{"issue":"5","key":"1853_CR89","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jaad.2018.02.010","volume":"79","author":"C Tziotzios","year":"2018","unstructured":"Tziotzios C, Lee JYW, Brier T, Saito R, Hsu CK, Bhargava K, Stefanato CM, Fenton DA, McGrath JA (2018) Lichen planus and lichenoid dermatoses: Clinical overview and molecular basis. J Am Acad Dermatol 79(5):789\u2013804","journal-title":"J Am Acad Dermatol"},{"key":"1853_CR90","first-page":"336","volume":"13","author":"C Vajaitu","year":"2018","unstructured":"Vajaitu C, Voiculescu VM, Draghici C, Solomon I, Lupu M (2018) Coexistence of psoriasis, vitiligo and oral lichen planus \u2013 a new variant of multiple autoimmune syndrome? Maedica 13:336","journal-title":"Maedica"},{"key":"1853_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24033038","author":"M Vi\u010di\u0107","year":"2023","unstructured":"Vi\u010di\u0107 M, Hla\u010da N, Ka\u0161telan M, Brajac I, Soto\u0161ek V, Prpi\u0107 Massari L (2023) Comprehensive insight into lichen planus immunopathogenesis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24033038","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1853_CR92","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/ijd.12887","volume":"55","author":"S Vohra","year":"2016","unstructured":"Vohra S, Singal A, Sharma SB (2016) Clinical and serological efficacy of topical calcineurin inhibitors in oral lichen planus: a prospective randomized controlled trial. Int J Dermatol 55(1):101\u2013105","journal-title":"Int J Dermatol"},{"key":"1853_CR93","doi-asserted-by":"crossref","unstructured":"Webster G (2015) Failure of lichen planopilaris to respond to ustekinumab. Dermatol Online J 21(11)","DOI":"10.5070\/D32111029305"},{"key":"1853_CR94","first-page":"75","volume":"8","author":"EJ Yang","year":"2018","unstructured":"Yang EJ, Beck KM, Liao W (2018) Secukinumab in the treatment of psoriasis: patient selection and perspectives. Psoriasis (Auckl) 8:75\u201382","journal-title":"Psoriasis (Auckl)"},{"issue":"2","key":"1853_CR95","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40257-020-00578-0","volume":"22","author":"K Yang","year":"2021","unstructured":"Yang K, Oak ASW, Elewski BE (2021) Use of IL-23 Inhibitors for the treatment of plaque psoriasis and psoriatic arthritis: A comprehensive review. Am J Clin Dermatol 22(2):173\u2013192","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"1853_CR96","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1177\/1078155219866248","volume":"26","author":"M Yilmaz","year":"2020","unstructured":"Yilmaz M, Mese SG, Celik U (2020) Nivolumab-induced lichen planus. J Oncol Pharm Pract 26(3):758\u2013760","journal-title":"J Oncol Pharm Pract"},{"key":"1853_CR97","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jdcr.2023.05.036","volume":"38","author":"SK Zemlok","year":"2023","unstructured":"Zemlok SK, Buuh S, Brown R, Murphy M, Hegde UP, Mallett JR (2023) Nivolumab-induced lichen planus responsive to dupilumab treatment in a patient with stage III C melanoma. JAAD Case Rep 38:23\u201326","journal-title":"JAAD Case Rep"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01853-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:54:54Z","timestamp":1757418894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01853-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":97,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01853-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}